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 Loss of PCDH19 function promotes neurogenesis of mouse and human neural 
stem/progenitor cells. 
 
 Neural stem/progenitor cells lacking functional PCDH19 also display a loss of 
characteristic apical-basal polarity. 
 
 Our data implicate asynchronous neurogenesis (or mosaic cellular heterochrony) as a 
mechanism contributing to PCDH19-GCE. 
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Abstract 
PCDH19-Girls Clustering Epilepsy (PCDH19-GCE) is a childhood epileptic encephalopathy 
characterised by a spectrum of neurodevelopmental problems. PCDH19-GCE is caused by 
heterozygous loss-of-function mutations in the X-chromosome gene, Protocadherin 19 
(PCDH19) encoding a cell-cell adhesion molecule. Intriguingly, hemizygous males are 
generally unaffected. As PCDH19 is subjected to random X-inactivation, heterozygous 
females are comprised of a mosaic of cells expressing either the normal or mutant allele, 
which is thought to drive pathology. Despite being the second most prevalent monogeneic 
cause of epilepsy, little is known about the role of PCDH19 in brain development. In this 
study we show that PCDH19 is highly expressed in human neural stem and progenitor cells 
(NSPCs) and investigate its function in vitro in these cells of both mouse and human origin. 
Transcriptomic analysis of mouse NSPCs lacking Pcdh19 revealed changes to genes involved 
in regulation of neuronal differentiation, and we subsequently show that loss of Pcdh19 
causes increased NSPC neurogenesis. We reprogramed human fibroblast cells harbouring a 
pathogenic PCDH19 mutation into human induced pluripotent stem cells (hiPSC) and 
employed neural differentiation of these to extend our studies into human NSPCs. As in 
mouse, loss of PCDH19 function caused increased neurogenesis, and furthermore, we show 
this is associated with a loss of human NSPC polarity. Overall our data suggests a conserved 
role for PCDH19 in regulating mammalian cortical neurogenesis and has implications for the 
pathogenesis of PCDH19-GCE. We propose that the difference in timing or ‘heterochrony’ of 
neuronal cell production originating from PCDH19 wildtype and mutant NSPCs within the 
same individual may lead to downstream asynchronies and abnormalities in neuronal network 
formation, which in-part predispose the individual to network dysfunction and epileptic 
activity. 
 
Introduction 
PCDH19- Girls Clustering Epilepsy (PCDH19-GCE) is a predominately female-specific 
epileptic encephalopathy caused by heterozygous loss-of-function mutations in the X-
chromosome gene Protocadherin 19 (PCDH19). The disorder is characterised clinically by 
the occurrence of seizures in girls at approximately 8-10 months of age followed by 
developmental regression with intellectual disability (ID) ranging from normal to profound 
(1-3). The disorder is also often associated with additional co-morbidities including Autism 
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Spectrum Disorders (ASD), language delay and other behavioural deficits. PCDH19 encodes 
a δ2-protocadherin, cell adhesion molecule, with a large highly conserved extracellular 
domain (among other protocadherins) and small cytoplasmic domain which shows variability 
among the protocadherin family (4, 5). Of more than 145 different (of 271 cases), reported 
PCDH19 disease causing variants, approximately 55% are nonsense, frameshift and splicing 
mutations which either ablate or severely truncate the PCDH19 protein, and the remaining 
45% are missense mutations, which cluster within the extracellular domain of the protein 
(Kolc et al. 2017, in review) (6).  Based on generally shared clinical phenotype across all 
mutations, it is predicted that all identified mutations are loss of function to the protein.  
 
The inheritance pattern of PCDH19-GCE is an intriguing feature of the disorder. Unlike the 
majority of X-chromosome linked disorders, PCDH19-GCE presents only in carrier (i.e. 
heterozygous) females. Hemizygous males are generally spared from the disorder, although 
behavioural disturbances and/or ASD have been identified in some transmitting males (6). 
PCDH19 has been shown to be subject to random X-inactivation in females (5, 7), thus 
affected females are a mosaic of cells which express either the wildtype (WT) PCDH19 or 
mutant PCDH19 allele. It has been proposed that the pathogenesis of PCDH19-GCE is driven 
by the cellular mosaicism within the brain, resulting in a partitioning of cell-cell connectivity 
and/or communication (8). Further support for this model comes from the identification of 
now multiple affected males with postzygotic somatic mutation in PCDH19 (and hence 
mosaicism akin to heterozygous females) whom display typical presentations of PCDH19-
GCE (8-10).  
 
The cellular and molecular mechanisms that lead to the clinical presentations of PCDH19-
GCE are still poorly understood. The first Pcdh19 knockout (KO) mouse models (produced 
by two independent groups, including our own) have been only recently reported (11-13). 
Neither models displayed an overt seizure phenotype in heterozygous females. Behavioural 
testing in one study revealed heterozygous animals had a decreased fear response, and both 
KO and heterozygous mice were hyperactive, particularly in response to stress.  Other 
behavioural features including anxiety, social interaction, working and spatial memory were 
normal. Thus the mouse models may not faithfully recapitulate the severity and clinical 
features of the human condition. In both reported mouse models, no evidence of any gross 
morphological disturbances to brain structure was identified. However, it was discovered that 
KO neurons displayed increased migration rates in vitro (13), suggesting that more in-depth 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 4 
analysis of the developmental processes and cellular architecture of the developing and adult 
brain is warranted. Indeed loss-of-function studies in zebrafish, has revealed more striking 
morphological phenotypes ranging from severe disruption of neural tube formation to milder 
disruption to only columnar architecture in the optic tectum depending on the technologies 
used (14, 15). It is intriguing that while the majority of patients have apparently normal 
Magnetic Resonance Imaging (MRI) reported, brain structural abnormalities including 
heterotopia in the left frontal cortex, atrophy of the hippocampus, cortical structural lesions 
and cortical dysplasia are evident in (at least) a small subset of patients (16-20).  Collectively 
these studies highlight both the potential roles of PCDH19 in early embryonic brain 
developmental processes, and also the limitations of the model systems, both mouse and fish, 
in the study of PCDH19-GCE. 
 
Consistent with potential roles in early neural development, Pcdh19 expression has been 
shown to be expressed in the developing as well as adult brain (5, 13, 21). Pcdh19 expression 
is first detected in the neural stem and progenitor cells (NSPCs) of the neuroepithelium at 
embryonic day 9 (E9) in mouse, and is expressed throughout the neuroepithelium by the 
onset of neurogenesis at E12.5 (22). At E15.5, the peak period of neurogenesis in mouse, 
Pcdh19 is highly expressed in both the NSPCs of the ventricular and sub-ventricular zones, 
the key proliferative zones of cortical development (13). At E10.5, heterozygous female mice 
with mosaic expression of Pcdh19 were shown to establish segregation of WT and KO 
Pcdh19 cortical progenitors, suggesting this is likely a key developmental period for the 
establishment of PCDH19-GCE pathogenesis (12). Despite expression in NSPCs of the 
developing brain, and emerging evidence of the role of PCDH19 in early brain developmental 
processes, it remains unknown as to the involvement of Pcdh19 in the function NSPC 
populations during cortical development, which play critical primordial roles in establishing 
future adult brain architecture and overall function.  
 
To identify evolutionary conserved roles of PCDH19 in mammalian cortical NSPCs, and the 
contribution these roles may play in the pathogenesis of PCDH19-GCE, we utilised both 
mouse Pcdh19 KO derived NSPCs and subsequently human patient derived (carrying loss-of-
function missense mutation) NSPCs, and assayed their differentiation behaviours in vitro. In 
both instances, we also mixed WT cells with PCDH19 Mutant (MUT)/KO cells to mimic 
mosaicism as seen in PCDH19-GCE. In both models, loss of Pcdh19 caused premature 
neurogenesis of NSPCs. We show that in human NSPCs, this premature neuronal 
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differentiation is associated with evidence of reduced apical-basal polarity of NSPCs. 
Intriguingly, mosaic cultures of NSPCs in general behaved similar to cultures of MUT/KO 
NSPCs. Our data thus provides evidence that heterochronic neural development may occur in 
patients with PCDH19-GCE, and potentially contributes to pathogenesis. Through the 
extension of this model, we propose that the asynchronous timing of neuronal cell production 
in vivo can contribute to subtle abnormal neuronal circuit assembly and dysfunction, 
culminating in epileptic activity. 
 
Materials and Methods: 
Animals 
The Pcdh19 KO mouse colony was used as described in (13). Unless otherwise described 
males and females were used in this study. Genotyping was performed as described in (13). 
All mice were maintained in same sex housing in a 12-hr day:night cycle with adequate 
sterile food and water under specific pathogen free conditions. The use of animals was 
approved under The University of Adelaide institutional ethics committee.  
 
Mouse NSPC culture 
Mouse NSPCs were isolated from e14.5 embryonic mouse cortex (telencephalic vesicles) and 
cultured as non-adherent neurospheres in the presence of 20ng/mL FGF and EGF as 
described (23). To generate the mosaic culture, neurospheres were passaged to single cells. 
Viable cell counts were determined using trypan blue and mixed (mosaic) cell lines formed 
by combining Pcdh19 WT (either fluorescently labelled or unlabelled) with Pcdh19 KO 
(either fluorescently labelled or unlabelled) NSPCs in a 1:1 ratio. All cultures were 
maintained for four passages (20 days) prior to use in neurosphere assays. 
 
Generation of lentivirus 
The lentiviral LeGO vectors (LeGO-C2, LeGO-G2) expressing eGFP or mCherry were 
obtained from Addgene (MA, USA) and have been described previously (24). Cell-free viral 
supernatants were generated by transient transfection of HEK293T packaging cells a gift 
from Associate Professor Simon Barry (The University of Adelaide, South Australia, 
Australia) as previously described (25, 26) 
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Transduction of NSPCs was performed at a multiplicity of infection (MOI) of 5. Pooled 
biological triplicates were generated for viral transduction by combining three Pcdh19 WT 
(Pcdh19
+/+
) embryos derived NSPC lines and three Pcdh19 KO (Pcdh19
-/-
) embryo derived 
NSPC lines, in equal numbers, immediately after isolation. Pcdh19 WT NSPCs were 
transduced with LeGO-G2 virus expressing eGFP and Pcdh19 KO NSPCs were transduced 
with LeGO-C2 virus expressing mCherry. Cells were exposed to the virus for 20 hrs. Cells 
were expanded for a further passage before isolation of fluorescently labelled cells using the 
FACSCalibur (Becton Dickinson; BD, North Ryde, NSW, Australia) flow cytometry system 
and further culture as neurospheres. 
 
Mouse neurosphere differentiation assay 
Neurospheres were passaged to single cells and plated at a density of 2.1x10
4 
cells/cm
2
 
(immunofluorescence analysis) or 3.3x10
4 
cells/cm
2
 (biochemical analysis) onto Poly-L-
Lysine (Sigma) coverslips in neurosphere medium without growth factors. Cells were 
incubated at 37˚C in 5% CO2 and collected at four days of differentiation for analysis. 
Immunofluorescent staining and fluorescence microscopy was used for cell count analysis. 
Duplicate experiments were done in pooled biological triplicate and analysed in technical 
triplicate with at least 1500 cells scored for each condition. 
 
Direct differentiation of mouse NSPCs 
Mouse NSPCs isolated from the e14.5 telencephalic vesicles were plated directly onto Poly-
L-Lysine (Sigma) coverslips at a density of 2.1x10
4 
cells/cm
2
 in neurosphere medium without 
growth factors. Cells were incubated at 37˚C in 5% CO2 and collected at seven days of 
differentiation for analysis. Immunofluorescent staining and fluorescence microscopy was 
used for cell count analysis. Duplicate experiments were done in pooled biological triplicate 
and analysed in technical triplicate with at least 1500 cells scored for each condition. 
 
Immunofluorescence 
Cells were fixed with 4% PFA at room temperature for 15 minutes. Cells were initially 
permeablised in 0.2% Tween20 in PBS (PBST) (or for neural rosettes 0.5% TritonX in PBS) 
for 5 minutes. Cells were then blocked for 1 hour in 5% horse serum in PBST. Antibodies 
were diluted in a solution of 0.5% Horse Serum in PBST at the following dilutions; Mouse 
anti-PKCλ(1:500; BD transduction laboratories), mouse anti-OCT3/4(1:200; Santa Cruz), 
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goat anti-NANOG(1:500; R&D Systems), rabbit anti-PAX6 (1:300; Covance), rabbit anti-
SOX2(1:200; Millipore), rabbit anti-TBR2(1:200; Abcam), rabbit anti-TBR1(1:300; Abcam), 
mouse anti-N-CADHERIN(1:300; BD transduction laboratories), rabbit anti-
VGLUT1(1:300; Synaptic Systems), rabbit anti-CUX1(1:300; Santa Cruz), SATB2(1:100; 
Abcam), rat anti-CTIP2(1:300; Abcam), mouse anti-NESTIN(1:300; Millipore), mouse anti-
NEUN(1:1000;Millipore), mouse anti-GAD65/67(1:500; Sapphire bioscience), 
VGLUT2(1:500; Millipore), mouse anti-βIII-Tubulin(1:300; Sigma), rabbit anti-βIII-
Tubulin(1:300; Sigma),guinea pig anti-DCX(1:300; Millipore), chicken anti-
MAP2(1:500;Millipore), Mouse anti-CNPase(1:1000; Millipore), goat anti-
GFAP(1:700;Sigma), donkey anti-mouse Alexa fluor488,555,647(all 1:700;Invitorgen), 
donkey anti-rabbit Alexafluor488,647(all 1:700;Invitrogen), donkey anti-rat 
Alexafluor488(1:700;Invitorgen), donkey anti-chicken Alexfluor555(1:500;Invitorgen), 
donkey anti-guinea pig Alexafluor555(1:500;Invitorgen). Primary antibody incubations were 
performed overnight in humid conditions at 4˚C. Secondary antibodies incubations were 
performed for 1hr at room temperature. When required cells were incubated with 0.1μM 
Phalloidin (Molecular Probes, Life Technologies) stain in 1% BSA in PBS for 30 minutes.  
Cells were mounted with ProLong® Gold Antifade mountant with DAPI (Life 
Technologies).  
 
Microarray 
RNA was extracted from cells using Trizol Reagent (Invitrogen) and the RNeasy mini 
extraction kit (QIAGEN) as per manufacturer’s protocol. Samples were treated with the 
RNase-free DNase Kit (QIAGEN) to remove genomic contamination. RNA was quantitated 
using the Nanodrop 1000 photo-spectrometer (Thermo fisher Scientific, USA). RNA was 
diluted to 100 ng/µL. cDNA was hybridised to the Affymetrix MoGene 2.0 St array 
(Affymetrix , CA, USA). RNA quality was confirmed using the Bioanalyser. Each sample 
done in biological triplicate with a total of 18 arrays (three genotypes; WT, KO and Mosaic 
and two cell types; neurospheres and differentiated neurospheres).  
 
Transcriptome analysis 
Data from the arrays was first inspected for the purpose of quality assessment using RLE and 
NUSE with no arrays showing significant departure from the average.  Data was then 
background corrected using RMA (DOI: 10.1093/biostatistics/4.2.249) and quantile 
normalised using the R package affy (27). Non-specific binding properties of each probe 
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were determined using a modified MAT model (28) trained on the set of antigenomic probes 
using quantile normalised and optical-background corrected data. The parameters for the 
MAT model were estimated across the entire dataset, and fitted values for each probe broken 
into 20 equally-sized bins based in their fitted values. This gave approximately 847 probes in 
each bin, with empirical background distributions estimated within each bin.  Fitted values 
were then obtained for perfect match (PM) probes based on their sequence content and the 
trained model. The fitted values were subtracted from the observed PM intensities on the log2 
scale to provide the residuals from the MAT model giving an empirical p-value for detection 
of signal above background (DABG). Fisher's method was used to combine the p-values for 
each probe across the entire set of arrays and those receiving a DABG p-value < 0.05 across 
all arrays were retained. After DABG analysis, 51.4% of probes (293281 of 571035) were 
included for estimation of expression levels. Array-specific expression estimates were 
obtained for the remaining genes, with an expression set formed selecting only genes 
containing 9 or more retained probes. Differential expression was defined based on an FDR-
adjusted p-value of <0.05 and log2 fold change (logFC) outside the range ± 1. Genes with 
raw p-value < lx10
-9 
were considered as differentially expressed regardless of fold change.  
 
Quantitative Real-Time PCR 
RNA was extracted from cells using Trizol Reagent (Invitrogen) and the RNeasy mini 
extraction kit (QIAGEN) as per manufacturer’s protocol. Samples were treated with the 
RNase-free DNase Kit (QIAGEN) to remove genomic contamination. cDNA was generated 
using superscript III® reverse transcriptase (Invitrogen) and random priming (Geneworks, 
Australia) as per manufacturer’s instructions. For mouse experiments; PCR reactions were 
prepared using SYBR green master mix (Biorad) and run on the StepOnePlus Real-Time 
PCR System (Applied Biosystems) using the following parameters; 95˚C for 5 minutes; 35 
cycles of  95˚C for 3 seconds, 60˚C for 30 seconds; followed by a melt curve set as follows: 
95°C for 15 seconds, 60°C for 1 minute followed by a 0.3% continuous ramp from 60 °C to 
95 °C with data collected using the StepOne V2.2.2 Software (Applied Biosystems). For 
hiPSC experiments; PCR reactions were prepared using Fast SYBR green master mix 
(Applied Biosystems) run on the QuantStudio™ 7-flex real-time PCR system using the 384 
well-plate format and the following cycling parameters; 95˚C for 20 seconds; 40 cycles of 
95˚C for 3 seconds, 60˚C for 30 seconds; followed by a melt curve set as follows: 95°C for 
15 seconds, 60°C for 1 minute followed by a 0.3% continuous ramp from 60 °C to 95 °C.  
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Data collected and analysed using the QuantStudio Real-Time PCR software v1.3 (Applied 
Biosystems). 
 
Human cell culture 
All cell culture work was performed based on the informed consent of patients under the 
approval of the human research ethics committee (Adelaide Women’s and Children’s 
Hospital). Human iPSCs were maintained on irradiated mouse embryonic fibroblasts (MEFs) 
as described previously (29). hESCs were cultured in the presence of 10 ng/mL bFGF. 
hiPSCs were cultured in 80-100 ng/mL bFGF. MEFs were supplied by Stemcore Australia. 
Cultures were mechanically passaged in a biological safety cabinet class II (VWR) using a 
dissecting microscope (Olympus SZX16 stereo microscope, Tokyo, Japan).  Feeder-free 
culture of hPSCs on ECM (Sigma) in MEF conditioned media was carried out as described 
(30). Cells were incubated at 37˚C in 5% CO2 with medium changes daily. PCDH19-GCE 
individual’s fibroblasts were cultured in RPMI medium supplemented with 10% heat 
inactivated fetal bovine serum and 2 mM L-glutamine (all from sigma-Aldrich, Australia). 
 
Episomal reprogramming of human fibroblasts 
Reprogramming experiments were all performed by the commercial services of Stemcore 
Australia. Primary human skin fibroblasts (1x10
6 
cells) were nucleofected with non-
integrating episomal vectors; pEP4 E02S ET2K & pEP4 E02S CK2M EN2L (31), using the 
Amaxa Human Dermal Fibroblasts Nucleofector kit, program U-023 (Lonza, VPD‐1001) as 
per manufacturer’s instructions. Immediately, following nucleofection cells were seeded on 
3x10 cm tissue culture dishes (0.76x10
4 
cells/cm
2
) on a MEF feeder layer in human fibroblast 
culture medium. Dishes were either incubated at; 37˚C in 5% CO2 in atmospheric oxygen 
conditions or 37˚C in 5% CO2 and 5% O2 (low oxygen conditions). After 2 days of culture 
the medium was changed to hiPSC complete medium containing 100 ng/mL of bFGF, with 
daily medium changes. After 10 days of culture the medium was changed to hiPSC 
conditioned medium with 100 ng/mL of bFGF. Plates were monitored and as colonies 
emerged they were isolated mechanically and replated onto a MEF feeder layer in complete 
hiPSC medium and incubated at 37˚C in 5% CO2 in atmospheric oxygen conditions for all 
plates.  
 
Screening of hiPSC clones 
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hiPSC clones were isolated and sub-cultured based on characteristic hiPSC morphology and 
growth characteristics. Clones were screened for the expression of pluripotency marker Tra-
1-60 using immunofluorescence (1:100). Standard G-banding chromosome karyotyping was 
carried out by Stemcore Australia, 15 metaphases analysed per sample. In vitro spontaneous 
differentiation assay and in vivo teratoma assays were both carried out by commercial 
services of Stemcore Australia.  
 
X-inactivation screening of hiPSC 
X-chromosome inactivation (XCI) was determined by both; Sanger sequencing of cDNA 
spanning the PCDH19 pathogenic mutation and the Human Androgen Receptor (HUMARA) 
PCR based assay (32).    
 
Human iPSC cortical differentiation protocol 
Cortical differentiation of hiPSCs was performed as previously described (33) with minor 
modifications. Modifications included; hiPSCs were plated as a high density single cell 
monolayer prior to cortical induction. Cortical induction was initiated by the addition of 5 
µM dorsomorphin and 10 µM SB431542 as described in (34). To select for cortical NSPCs, 
rosettes were manually selected in a biological safety cabinet class II (VWR) using a 
dissecting microscope (Olympus SZX16 stereo microscope, Tokyo, Japan) and replated in 20 
ng/mL FGF and 1 µM ROCK inhibitor for one day. The H9 control human embryonic stem 
cell line (35) was also used to validate the optimised differentiation protocol.  
 
Microscopy 
Fluorescence was observed using the Zeiss AxioImager M2 fluorescent microscope (Carl 
Zeiss, Germany). Fluorescent images were acquired with the AxioCam MRm high resolution 
camera and the AxioVision software Vs4.9.1.0 (Carl Zeiss, Germany). Neural Rosettes 
fluorescence was observed on Nikon Ti E live cell microscope with an automated stage 
(Adelaide microscopy, The University of Adelaide). Fluorescent images were acquired with a 
Photometrics camera and the NIS elements software (Nikon instruments Inc, NY, USA).  
 
Neural rosette morphological analysis 
Neural rosette images acquired using the Zeiss fluorescent microscope were acquired 
sequentially at 100X magnification until the whole neural rosette colony was captured. Using 
the Image J plugin, stitching; Grid/collection (36), the neural rosette colony was 
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reconstructed as a single image for analysis.  To avoid selection bias, neural rosette colonies 
were selected for imaging based on their position on the slide. Neural rosette images acquired 
using the Nikon live cell microscope were selected based on their position on the slide with 
12 locations selected for imaging, using an 8x8 field of view grid at 100X magnification. 
Using image J software, the area of the neural rosette colony was determined using the 
freehand tracing tool to trace the outer edge of the neural rosette colony. The number of foci 
and neural rosette structures was then counted within each colony using the cell counter 
plugin based on phalloidin stain. Foci were identified based on a diameter <10µm and no 
visible central lumen. Polarised structures were identified as having a central lumen and 
being >10µm in diameter. The number of foci and polarised structures within each rosette 
colony was then determined relative to the area of the neural rosette colony as a measure of 
polarity. To measure the lumen area, the freehand tracing tool in ImageJ was used to trace 
around the periphery of the structures. The total area of the polarised structures was then 
determined relative to the area of the neural rosette colony.  Neurons were detected 
immunofluorescently using a β-III tubulin antibody (as described above) and counterstained 
with DAPI to identify single cells. The number of neurons on the edge of the neural rosette 
colony was then determined by using the Image J cell counter plugin, counting the cells 
which were co-labelled with β-III tubulin and DAPI. The number of neurons was determined 
relative to the area of the neural rosette colony.  
 
Results: 
Loss of Pcdh19 in mouse NSPC drives accelerated neurogenesis.  
To investigate the pathogenesis of PCDH19-GCE and the effect of loss of Pcdh19 function 
on neural development, and NSPCs in particular, we used a recently described Pcdh19 KO 
mouse (13). Mouse NSPCs (mNSPCs) were extracted from both WT and KO telencephalic 
vesicles at E14.5 and cultured ex-vivo in an undifferentiated state as non-adherent 
neurospheres (23). To create mosaicism observed in PCDH19-GCE, mNSPCs from WT and 
KO were also mixed in a 1:1 ratio to generate a Pcdh19 WT:KO (Mosaic) neurosphere 
culture (Figure 1A). To study the cell autonomous role of Pcdh19 in NSPC differentiation, 
mNSPCs from neurospheres were dissociated into single cells, and plated onto a poly-L-
lysine substrate in the absence of growth factor which induces differentiation of mNSPCs 
into mature cell types of the brain (namely, neurons, astrocytes and oligodendrocytes). 
Initially, we sought an unbiased analysis of the role of Pcdh19 in mNSPC differentiation: we 
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isolated mRNA from both undifferentiated and differentiated mNSPC cultures (WT, KO and 
Mosaic) and subjected them to a genome-wide gene expression analysis using Affymetrix 
MoGene 2.0 St microarrays (Figure 1A and Supplementary figure 1). As expected, Pcdh19 
was one of the most significantly differentially expressed (DE) genes in all samples, with 
expression in the Mosaic cultures being intermediate to WT and KO cultures (Supplementary 
figure 1B). Principal component analysis (PCA) of data sets derived from the undifferentiated 
mNSPC cultures suggested that Pcdh19 is not having a significant impact on the overall 
transcriptional signature of undifferentiated mNSPCs, as all three culture types clustered 
together (Figure 1B). Data sets derived from cultures of differentiated mNSPCs all separated 
away from the undifferentiated mNSPC cluster, however the Mosaic and KO cultures 
clustered together, and separated from the WT cultures (Figure 1B). This suggested that 
differentiation of KO and Mosaic mNSPC cultures was altered compared to WT cultures. 
Given the Mosaic and the KO differentiated mNSPC cultures clustered together in the PCA, 
and no highly significant genes were identified as DE between the Mosaic and the KO 
cultures, we compared WT to KO cultures in subsequent analysis. To focus on the process of 
differentiation itself, we identified the genes that were differentially expressed between 
undifferentiated and differentiated cultures, and then compared this gene list between WT 
and KO mNSPC cultures (Supplementary figure 1C-1E).  This analysis thus targets 
identification of potential pathways or cellular mechanisms regulated by Pcdh19 during 
mNSPC differentiation. Filtering of the datasets (see material and methods) identified 920 
significantly DE genes in WT and 904 significantly DE genes in KO, occurring across 
differentiation (Supplementary figure 1C-E).  Of these 71.6% were conserved between the 
two genotypes, with 302 significantly DE genes identified as unique between WT and KO 
differentiation (Figure 1C). This unique gene list was submitted for enrichment analysis using 
the enrichr software (37), to identify significant gene ontology (GO) terms or pathways. The 
15 most significantly enriched GO terms for biological processes, based on the enrichr 
combined score, included six neuronal process associated with neuronal differentiation and 
maturation (Figure 1D). This included neuronal migration, which we have previously shown 
to be accelerated in Pcdh19 KO neurons (13).  Intriguingly, the most significantly enriched 
GO term for cell component, was cell-cell adherens (Supplementary figure 2C), which was of 
interest given Pcdh19 is a protocadherin itself, and  has also been shown to interact with N-
cadherin an integral component of adherens junctions in mNSPCs (38).  Additionally, KEGG 
pathway analysis also showed enrichment of pathways known to be involved in cell fate 
decisions (e.g. proliferation vs differentiation) of mNSPCs, including the Hippo signalling 
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pathway (Figure 1E). In the top 15 enriched pathways both estrogen and oxytocin signalling 
pathways were also identified, which have been previously been implicated in PCDH19-GCE 
(39). Further analysis of the 302 DE genes identified clusters of genes with bonafide roles in 
cell-cell adhesion and/or cadherin signalling, neuronal differentiation and maturation, and 
negative regulators of cellular proliferation. (Figure 1F). In aggregate, the transcriptomic 
analysis suggests that (1) mNSPC differentiation in KO and Mosaic cultures were similar to 
each other and distinct from WT, and (2) implicate roles of Pcdh19 in mNSPC proliferation, 
neuronal differentiation and neuronal maturation.  
 
Given the above data, we next directly addressed if Pcdh19 effects the differentiation of 
mNSPCs. As per above, we again plated at low density undifferentiated WT and KO 
mNSPCs derived from neurospheres onto a Poly-L-Lysine substrate and allowed them to 
differentiate for four days. Cultures were then immunofluorescently stained using antibodies 
against cell type specific marker proteins to identify mNSPCs (Pax6) and derived post-
mitotic cell types of the three major neural cell lineages, namely neurons (β-III Tubulin), 
astrocytes (GFAP) and oligodendrocytes (CNPase). Cell counts were then performed and 
percentage of each cell type in the cultures determined (Figure 1G and H).  There was a 
significant increase in the percentage of neurons present in the KO cell population compared 
to WT cultures (59.7% compared to 50.4% respectively; Figure 1H). Given the sex-bias of 
PCDH19-GCE we compared neuronal differentiation between male and female derived 
mNSPCs. Increased percentage of neurons in the KO cell population was observed regardless 
of the gender of the cells (Supplementary figure 3), suggesting no sex-specific effect on 
neuronal differentiation. This increase in neurons was accompanied by a decrease in the 
percentage of oligodendrocytes in the KO cells (6.18%) as compared to WT (10.44%). These 
results were supported further by RT-qPCR analysis of the mRNA expression of different cell 
type marker genes (Supplementary figure 4A). To track the behaviour of WT and KO cells in 
Mosaic cultures, we first fluorescently labelled the individual populations (KO cells labelled 
with lentivirus expressing mCherry, and WT cells likewise labelled with EGFP) prior to 
mixing to create the Mosaic culture. We found that in mosaic cultures, it was only the KO 
cells that prematurely differentiated into neurons (at similar rate to cultures of KO cells only) 
whilst WT cells behaved normally (similar to cultures of WT cells only). This data suggest 
that loss of Pcdh19 can impact neurogenesis in a cell autonomous manner (Supplementary 4B 
and C). We also explored if differences in the proportions of inhibitory or excitatory neuronal 
subtypes within WT and KO cultures existed, but found no evidence as such suggesting that 
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Pcdh19’s role in mNSPCs is not restricted to mNSPCs of either dorsal or ventral identify 
(from which excitatory and inhibitory neurons are derived respectively) (Supplementary 
figure 4D and E). These data reveal that Pcdh19 has a role in limiting the rate of neurogenesis 
of mNSPCs. 
 
Generation of PCDH19-GCE hiPSC lines as a source of human NSPCs. 
Whilst there are many conserved developmental mechanisms and features between mouse 
and human brain development, there are also many differences. In particular, whilst NSPCs 
have similar fundamental functions (e.g. self-renewal, multipotency, spatial and temporal fate 
restrictions), NSPCs in human must persist and function over a greatly extended period of 
time, and have greater diversity (e.g. outer radial glial cells) compared to mouse. Thus we 
sought evidence for conserved role of PCDH19 in neurogenesis of human NSPCs (hNSPCs) 
to both confirm and extend our findings in mouse. As a source of hNSPCs, we set out to 
generate relevant human induced pluripotent stem cells (hiPSCs), from which hNSPCs can be 
generated using directed neural differentiation techniques. As hiPSCs have yet to be 
generated, we employed our resources of skin fibroblast cell lines derived from individuals 
with PCDH19-CGE, with pathogenic (loss-of-function) mutations in PCDH19.  Three 
unrelated individuals with different pathogenic PCDH19 mutations were selected for hiPSC 
generation: Two females with PCDH19-GCE (Individual 1 and Individual 2) and an 
unaffected transmitting male (Individual 3). Individuals 1 and 3 have different pathogenic 
missense mutations in exon1 [(NM_001105243.1); c.1129G>C, p.Asn377His and 
c.1671C>G p.Asn557Lys, respectively] and Individual 2 has a nonsense mutation in the 
cytoplasmic domain [c.2342dupA, p.Ile781Asn fs*3]. Selected individual’s details are 
described (supplementary data) and summarised in figure 2.  
 
Human skin fibroblast cell lines derived from each individual were reprogrammed using non-
viral, non-integrative episomal reprogramming as previously described (31). Putative hiPSC 
clones were isolated based on morphology and growth characteristics over several passages, 
and expression of the pluripotent stem cell markers protein Tra-1-60 (as assessed via 
immunostaining). As PCDH19 is subjected to random X-inactivation in females, 
reprograming of the female lines provided an opportunity to generate both WT and mutant 
expressing isogenic clones. As such, the active X-chromosomes in putative hiPSC clones 
derived from the female individuals was identified using a combination of X-chromosome 
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inactivation assays (AR micro-satellite analysis), allele specific mRNA expression and sanger 
sequencing of PCDH19 cDNA species (Figure 2A and data not shown). Intriguingly we 
found that all putative female hiPSCs clones derived (n=25 in total tested) expressed 
exclusively the X-chromosome harbouring the PCDH19 WT allele. No clones were identified 
expressing the PCDH19 Mutant allele (Figure 2B). Thus we focussed on isolating mutant 
PCDH19 hiPSCs from the male (hemizygous) individual. After multiple rounds of 
reprogramming with increased plating density (1.14x10
4
/cm
2
 in two 100mm dishes) and 
incubation at low oxygen conditions (5% O2), three putative hiPSC clones were isolated from 
the male individual (Individual 3). The reprogramming efficiency to isolate mutant PCDH19 
hiPSCs was much lower than for WT (0.0002%). These data suggest a selective advantage is 
conferred by expression of WT PCDH19, however hiPSCs can be generated with loss of 
PCDH19 function albeit at much reduced efficiency. Two of the three putative mutant hiPSC 
clones from Individual 3 were shown to maintain a normal karyotype, and subjected to 
further characterisation of their pluripotent state. Both lines expressed pluripotency marker 
proteins; OCT4, NANOG, SOX2 and Tra-1-60 (Figure 2C and D), and were shown to be able 
to differentiate into cells from all three embryonic germ layers using both an in vitro 
spontaneous differentiation assay and an in vivo teratoma assay (Figure 2E). All together, 
these data suggest that whilst PCDH19 benefits the reprograming of fibroblasts into hiPSCs, 
bonafide hiPSC lines lacking PCDH19 function can be created, albeit at much lower 
frequency. In summary, we were successful in creating two hiPSC harbouring hemizygous 
loss-of-function PCDH19 missense mutation (PCDH19
Asn557Lys
), which provided the vital 
resources to study the role of PCDH19 in human NSPCs relevant to the pathogenesis of 
PCDH19-GCE. 
 
PCDH19 is highly expressed in cortical hNSPCs 
To generate hNSPCs and neurons from our hiPSC resources, we first optimised a previously 
published method of directed neural differentiation of human pluripotent stem cells (33). Our 
method employs initial plating hiPSCs as single cells at high density, dual-SMAD inhibition 
and ongoing adherent 2-dimensional culture. The method induces hNSPCs of dorsal cortical 
identity, and thus align with our previous studies of the same cells in mice. Chronological 
developmental hallmarks of the culture include induction of neuroepithelial sheet, generation 
of hNSPCs assembled as so called neural rosettes, hNSPC expansion, and with extended 
culture (up to 90 days), generation of both lower and upper layer excitatory cortical neurons 
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hence recapitulating the full neurogenic potential of in vivo NSPC equivalents; Figure 3A 
(33). Our optimised method was robust across several hiPSC and hESC lines. In the first 
instance we used this model of in vitro human cortical development to investigate the 
expression of PCDH19 mRNA. PCDH19 is increased upon neural induction, with expression 
peaking at the neural rosette stage and maintained through to 90-day cortical neuron stage, 
suggesting prominent roles of PCDH19 might exist early in cortical development, and in 
hNSPCs in particular (Figure 3B). Next, we employed neural differentiation of our control 
(C11 hiPSC line (29); WT) and PCDH19 Mutant (MUT) hiPSCs to investigate the function 
of PCDH19 in hNSCPs. Furthermore, to also model PCDH19-GCE, we also created mosaic 
cultures (Mosaic), by mixing WT and MUT hiPSC at a 1:1 ratio prior to being plated as 
single cells for neural induction (Supplementary figure 5). All three culture types were 
simultaneously subjected to neural induction and mRNA collected across the developmental 
hallmark stages of differentiation. Initially, we measured the expression of PCDH19 itself. 
The expression of PCDH19 was not significantly different between cultures across most 
developmental stages, but intriguingly, at the rosette stage, expression was significantly 
increased in both the MUT (fold change=4.97, P=0.0024) and Mosaic (fold change=4.17, 
P=0.0349) compared to WT cultures, suggesting a possible feedback response (Figure 3C). 
Collectively, these results suggest that hNSPCs present at the rosette stage of hiPSC neural 
differentiation may be particularly reliant on PCDH19 function. 
 
Pathogenic loss-of-function mutation in PCDH19 causes accelerated human NSPC 
differentiation and neuronal maturation. 
Next we used mRNA expression analysis of marker genes specific to the different 
representative cell types present in the cultures across the developmental stages to determine 
if PCDH19 regulated neural differentiation. PAX6 is a marker of dorsal cortical hNSPCs and 
expressed first in NSPCs of the neuroepithelial sheet, and maintained in hNSPCs at 
subsequent stages. We saw no difference in PAX6 expression at the neuroepithelial sheet 
stage suggesting PCDH19 has no effect on neural induction of hiPSCs (Figure 4A). In further 
support, we also saw no difference in expression of  TBR2, a basal progenitor marker, and 
DCX, a pan-neuronal marker at this stage. At the neural rosette stage PAX6, TBR2 and 
NEUROG2 (marker of neural progenitors and radial glial cells) were all significantly 
decreased in both the MUT and the Mosaic culture types, suggesting loss of PCDH19 
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function caused a decrease in the number of hNSPCs (Figure 4B). Given our findings in 
mouse NSPCs, we considered if premature neurogenesis of NSPCs might explain the 
decrease in expression of hNSPC marker genes. The expression of the pan-immature 
neuronal maker genes DCX and TUBB3 was slightly (albeit not significantly) increased, as 
was the  excitatory neuronal marker gene, VGLUT1, collectively providing evidence of 
increased neurogenesis (Figure 4B). No difference in GABAergic inhibitory neuronal marker 
gene GAD67 was identified. Increased expression of neuronal marker genes persisted at later 
stages of differentiation with an even greater increase in VGLUT1 and DCX expression 
observed in day 70 neurons in both the MUT and the Mosaic cultures compared to WT but 
neither reached significance (Figure 4C). Additional Glutamatergic marker genes GRIN1 and 
NEUROD6 showed similar increased expression, suggesting an increase in Glutamatergic 
excitatory neurons in the MUT and Mosaic cultures.  A premature state of differentiation of 
the cultures, would also be consistent with a quicker change in expression from the early 
Glutamatergic excitatory neuronal marker, VGLUT2 to the mature Glutamatergic excitatory 
neuronal marker, VGLUT1. At the day 70 neurons stage, VGLUT2 expression was decreased 
between WT and MUT (fold change=0.112, P=0.0541) (Figure 4C). At day 90 stage (Figure 
4D), this decrease reached significance with expression decreased between both WT and 
MUT (fold change= 0.327, P=0.0018) and between WT and Mosaic (fold change= 0.329, 
P=0.0013). The level of expression in the Mosaic neurons was in-between WT and MUT. 
Together, the marker gene analysis was consistent with a model whereby loss of PCDH19 
function causes premature differentiation of hNSPCs first seen at the neural rosette stage. 
 
To more directly address if loss of PCDH19 results in increased numbers of neurons at the 
rosette stage of neural differentiation, we used immunofluorescent identification of newly 
born neurons (via immunostaining of βIII-tubulin) and cell counts. Neural rosette colonies are 
known to provide a spatial gradient of differentiation, in which newly born neurons migrate 
to the periphery and subsequently undergo maturation (40, 41).  The number of peripheral β-
III Tubulin positive cells were counted relative to the total area of the neural rosette colony 
(Figure 5A and B). Both the MUT and Mosaic cultures had a significant increase in the 
number of neurons relative to WT (4-fold and 3.82-fold respectively). We reasoned that if 
neurons are being born earlier in these cultures, their maturation (for example neurite growth) 
would also be advanced. Indeed, whilst the average primary neurite length for neurons in WT 
cultures was 155 µm, neurons in MUT and Mosaic cultures were significantly longer (248 
and 238 µm respectively; Figure 5C and D). Thus, aligned with both our findings in mouse 
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NSPCs, and our marker gene analysis of human NSPCs, these data suggest that loss of 
PCDH19 function is associated with increased rate of NSPC differentiation. 
 
Pathogenic loss-of-function mutation in PCDH19 diminishes the polarity of human 
NSPCs 
The assembly of hNSPCs into rosette structures arises through the establishment of apical-
basal polarity. This is evidenced initially by the focal accumulation (Foci) of apically 
localised polarity marker proteins in a few hNSCPs (41) (Figure 6A). With the subsequent 
expansion of polarised hNSPCs, a rosette structure is formed, featuring a central lumen 
demarcated by the apical surface of the cells, the size of which reflective of the number of 
apical-basal polarised hNSPCs (42). In opposition, differentiation of hNSPCs into neurons 
(which subsequently migrate radially outward to the colony periphery) is associated with loss 
of hNSPC polarity. This relationship between hNSPC polarity and hNSPC expansion (and 
likewise the inverse relationship of polarity with differentiation) is well established (43). 
Given that PCDH19 (1) is a cell-cell adhesion molecule, (2) interacts with N-CADHERIN, 
(3) and was found to regulate signalling pathways involved in cell-cell adhesion in mouse 
NSPCs, all of which have the potential to influence NSPC polarity, we questioned if the 
premature differentiation of NSPCs lacking PCDH19 function might be related to decrease in 
NSPC polarity. To address this, we initially identified markers of polarity in our cultures. As 
with previous reports (42, 44), immunofluorescent staining of cultures with antibodies 
towards N-CADHERIN and AFADIN (AF6), reliably identified the apically localised cell-
cell-adhesion structures (demarcating foci and rosette structure lumens), which were also 
identified with the filamentous actin stain Phalliodin (Figure 6B). In an initial attempt to 
capture any overt alteration to polarity, we compared the expression of the apical marker N-
CADHERIN mRNA across the culture types. N-CADHERIN, was slightly decreased (albeit 
not significantly) in both the MUT and Mosaic cultures compared to the WT (Figure 6C). 
Phalloidin stain was used next in a morphometric analysis to more accurately compare 
polarity between the three culture types.  All three culture types (WT, MUT and Mosaic) 
contained colonies consisting of numerous foci and neural rosette structures (so called neural 
rosette colonies). No difference in the average rosette colony area was found between the 
three different culture types (Figure 6D).  To identify changes in the ability of the cells to 
acquire polarity, the density of polarised foci and polarised neural rosette structures 
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(structures with a clear lumen) were quantified within neural rosette colonies (Figure 6E). 
Whilst there was no significant difference in the density of foci between the three culture 
types, there was a significant decrease in the density of neural rosette structures between both 
WT and MUT (63% decrease, P=0.007) and WT and Mosaic (34.4% decrease, P=0.0038) 
cultures (Figure 6F and G). The overall proportion of neural rosette structures to foci was also 
significantly decreased in the MUT cells relative to WT (31.4% decrease, P=0.0014, Figure 
6H). This trend was also observed in the Mosaic culture type but did not reach significance. 
Given the density of foci was not changed between the three culture types, this suggested that 
the reduction in neural rosettes structure density may be attributed to a reduced ability of 
hNSPCs to maintain polarity, rather than a reduced ability to acquire cell polarity. 
Collectively, a reduction in the number polarised hNSPCs in neural rosette structures would 
result, which can be inferred from measuring the lumen size of rosette structures (40). Indeed, 
rosette structures in both the MUT and the Mosaic cultures had a significant reduction in the 
average lumen area relative to WT (45.98% decrease, P=0.0142 and 58.79% decrease, 
P=0.0044 respectively, Figure 6I). Altogether, these data reveal that PCDH19 promotes the 
maintenance hNSPC polarity. 
 
Discussion 
PCDH19-GCE is a debilitating epileptic disorder, commonly associated with 
neurodevelopmental regression.  No effective treatment is currently available for this 
disorder, highlighting the need to better understand the roles of PCDH19 function during 
human brain development. Expression of PCDH19 in mNSPC populations of the developing 
brains of mice (13) provided initial evidence that PCDH19 may regulate the function of these 
cells, and in this study we extend this finding by showing expression elevated in human 
NSPCs also. We thus focussed our studies on NSPCs because they represent the earliest 
neural cell arising during development in which PCDH19 is likely to be required for 
function. Our major findings are that loss of PCDH19 function causes premature or 
accelerated neurogenesis of NSPCs, which was associated with a reduction in NSPC polarity. 
In addition, we show that in mosaic cultures of WT and MUT/KO NSPCs, which model the 
pathogenic cellular composition in PCDH19-CGE patients, NSPCs behaved similar to 
cultures of KO cells only. By interrogating PCDH19 function in both mouse and human 
NSPCs, our approach was designed at revealing conserved functions of PCDH19. In mouse, 
we used our Pcdh19 KO mouse to isolate mNSPCs from the dorsal cortex to address impact 
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of loss-of-function. In human, we employed hiPSC reprograming of patient derived 
fibroblasts, in which loss of function is implicated based on clinical presentation of PCDH19-
GCE. In a parallel study, we have extensively shown that the p.Asn557Lys mutation in the 
hiPSC lines carried forward in our studies is indeed loss-of-function using cell-reporter based 
assays, as well as in silico and protein modelling data (Pham et al, in preparation,(39)). It was 
intriguing that loss of PCDH19 function severely impacted our reprogramming efficiency, 
with strong selection bias during reprogramming in favour of an active WT X-chromosome 
in hiPSCs derived from female fibroblast cells. It is unclear if PCDH19 has a functional role 
in reprograming, or if this result is driven by another X-chromosomal feature, as has been 
previously reported in reprogramming of female cells, for example from female patients with 
(X-linked) MECP2 mutations in Rett Syndrome patients (45). Whilst this hindered our ability 
to derive female isogenic cell lines, we were able to eventually (after multiple rounds of 
reprograming) isolate and fully validate hiPSCs derived from a male individual with 
hemizygous loss-of-function PCDH19 missense mutation. Given that males with somatic 
PCDH19 mutation also present with PCDH19-GCE, and the daughter of this individual has 
PCDH19-GCE, we used this cell line to model the disorder and PCDH19 loss-of-function. 
These are the first reported hiPSC lines created to study PCDH19-GCE. 
 
To best compare across mouse and human, we used NSPCs of dorsal cortical identity, 
isolated either by careful dissection (for mouse) or by a directed pluripotent stem cell 
differentiation protocol (for human). As validation, both mNSPCs and hNSPCs were found to 
express the cardinal dorsal cortical NSPC marker PAX6. Several lines of evidence supported 
a role PCDH19 in the suppression of NSPC differentiation, and neurogenesis (the production 
of neurons) in particular. Differentiation of mNSPCs lacking Pcdh19 resulted in gene 
transcriptional differences, albeit of modest magnitude which is consistent with subtle nature 
of the KO mouse phenotype (13). Nonetheless, gene ontology and pathway analysis of 
differentially expressed genes highlighted processes involved in the differentiation and 
maturation of neurons. This included telencephalic cell migration (which we have previously 
shown is accelerated in the Pcdh19 KO neurons (13)), as well as synaptic transmission and 
axiogenesis (for which protocadherins are known to be involved (46-48)). In particular, genes 
with known roles in neuronal differentiation of NSPCs, and neuronal maturation were 
primarily upregulated in the KO cultures, and downregulated in the WT cultures. More in-
depth analysis of these transcriptomic differences using RNAseq technologies may provide 
additional support and mechanisms underpinning the premature neurogenesis phenomena, for 
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example enabling the interrogation non-coding RNAs such as miRNAs which are known to 
also regulate neurogenesis (49). Encouraged by our transcriptomic analysis we directly 
quantified  cell types present in differentiated cultures via immunofluorescence and identified 
that loss of Pcdh19 increased neurogenesis of mNSPCs. This phenomenon was conserved (in 
general) in hNSPCs, where again, both marker gene expression and quantification of 
neuronal cell types provided evidence of significantly increased neurogenesis. In further 
support, neurons in these cultures were also found to be at a more advanced stage of 
maturation (i.e. as reported by VGLUT1, NEUROD6 and GRIN1 expression and neurite 
growth) compared to their WT counterparts. Our findings that loss of PCDH19 function 
increased neurogenesis from both mouse and human cortical NSPCs are aligned with recent 
studies on mir-484, shown to promote mNSPC differentiation specifically through inhibition 
of Pcdh19 expression in mouse cortices (50). Thus we propose that these functions of 
PCDH19 in early NSPC populations may contribute to pathology in PCDH19-CGE by 
altering the developmental kinetics or trajectory of NSPCs (see below). It also very likely that 
functions of PCDH19 in other cell types, and at different developmental times will also be 
relevant to pathology. For example, whilst not studied for Pcdh19 directly, it is well 
established that protocadherins play critical roles in axon guidance and bundling, synaptic 
recognition and connectivity, and overall neuronal circuitry. Conditional deletion models will 
be required to fully dissect the role of PCDH19 across different developmental processes, and 
to best identify the dominant drivers of pathology in PCDH19-GCE. 
 
During hiPSC neural differentiation, the expression of PCDH19 was significantly 
upregulated at the neural rosette stage compared to preceding neuroepithelial sheet stage. 
Intriguingly, in the absence of functional PCDH19 protein, we observed a significant up-
regulation of PCDH19 mRNA (compered to WT cultures) specifically at this rosette stage of 
culture, indicative of a compensatory feedback mechanism. A major difference between 
hNSPCs at the neural rosette stage compared to the neuroepithelial stage is the establishment 
and maintenance of overt apical-basal polarity. The defining feature of polarised epithelia is 
the discrimination of apical from basolateral membranes, which is demarcated by the 
presence of cell-cell adhesion complexes including adherens and tight junctions. Pcdh19 has 
been shown to be localised to these structures in NSPCs, both during mouse cortical 
development in vivo (13), and in neural rosettes in vitro (51), and furthermore, has been 
shown to interact with N-cadherin (15), the major cell-cell adherens junctional protein in 
NSPCs. Our investigation on cells lacking functional PCDH19 indeed identified it as a 
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positive regulator of NSPC polarity. Specifically, cultures of hNSPCs lacking functional 
PCDH19 had significantly reduced densities of rosettes structures, and rosette structures 
themselves had reduced luminal size, all together indicative of fewer numbers of polarised 
NSPCs (42, 43). That MUT cultures had normal density of the polarity initiating ‘foci’ 
structures, suggested that PCDH19 might regulate maintenance rather than establishment of 
polarity, although this requires further interrogation. The dependency of NSPC self-renewal 
(i.e. proliferation in the undifferentiated state) on apical-basal polarity is well established but 
the molecular mechanisms are not yet fully understood. A classic illustration of this 
phenomena is provided by studies of mice lacking N-cadherin, where NSPC apical-basal 
polarity is lost, and is associated with cell-cycle exit, premature neuronal differentiation, and 
accelerated neuronal migration (52-54). Similar results have been observed for deletion of 
other adhesion junction proteins (e.g. β-catenin (55), AF6 (56), αE-Cadherin (57)) and 
polarity proteins (e.g. Par3 (58), aPKC (59), Cdc42 (60)). Our data provide further support, 
whereby hNSPCs lacking functional PCDH19 display both reduced polarity associated with 
evidence of reduced hNSPC numbers (e.g. reduced Pax6 expression) and premature 
neurogenesis. Whether PCDH19’s impact on polarity is the driver of altered neurogenesis (or 
vice versa) remains to be determined, but PCDH19 is a cell-cell adhesion molecule and 
interactors of PCDH19, including N-cadherin and components of the actin remodelling wave 
regulatory complex (NAP1 and CYFIP2), are known regulators of NSPC polarity (61) (62). 
Furthermore, our transcriptomic analysis identified a class of DE genes with roles in cell-cell 
adhesion and cadherin signalling including Ctnna2, Vcl and Pvrl3 which all participate in 
signalling from adhesion sites to the cytoskeleton  (63-67). Collectively, these data support 
the involvement of PCDH19 in the promotion of NSPC polarity, with further interrogation 
required to elucidate the molecular mechanism.  
 
The major motivation of our study was to better understand the pathogenic mechanisms of 
PCDH19-GCE, and as such the principle challenge is to reconcile our data with the modes of 
PCDH19-GCE inheritance, in which only heterozygous females are affected, and hemizygous 
males are (largely) unaffected. This provides two posits for models of pathogenesis: (1) that 
any phenotype derived from KO cells should be considered as tolerated in normal human 
development, and (2) that mosaic cultures would be expected to have a phenotype that is 
distinct from WT and KO.  Relating to the first posit, we propose that differences in NSPC 
behaviour (WT and MUT/KO) would indeed be tolerated, but only so long as cell behaviour 
(i.e. neurogenesis rate) is uniform / synchronised during development (i.e. as in either WT or 
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MUT/KO individuals). It is noteworthy that behavioural disturbances in some ‘carrier’ male 
individuals have been reported (6). In heterozygous individuals however, we postulate that 
the cellular mosaicism causes non-uniform / asynchronous NSPC behaviour, which can be 
viewed as a cellular heterochrony (differencing rates of development) of neurogenesis. The 
sequential order of neurogenesis is important for the formation of complex neural circuits 
with temporal and spatial precision (68). That the timing of birth of neurons dictates their 
identity, spatial location and downstream network connectivity and circuitry suggests that 
heterochrony of neurogenesis could result in abnormal cellular interactions and neuronal 
networks, predisposing the individual to network dysfunction and epileptic activity. This 
model is complementary to the proposed “cellular interference model’ which has been 
postulated to underlie PCDH19-GCE in that cellular heterochrony provides a mechanism by 
which the establishment of the abnormal neuronal cell interactions can arise. The model 
might also in-part explain why the Pcdh19 heterozygous mice lack the overt epileptic 
phenotype, as the modest changes in neurogenesis we observe might not have large impact 
over the developmental trajectory of NSPCs during the relatively short mouse neurogenic 
period (~8 days, E11-18), compared to the protracted neurogenic period in human (~150 
days, GW8-30). Our data was however more challenging to reconcile with the second posit; 
that mosaic cultures would be expected to have a phenotype that is distinct from WT and KO. 
Interestingly, in the majority of our assays (including transcriptomics, marker gene 
expression, cell quantification and morphometric analysis), the mosaic cultures of NSPCs 
showed a phenotype similar to cultures consisting only of MUT/KO cells. We excluded any 
strong effect of ‘culture skewing’ towards mutant cells within mosaic cultures using X-
Chromosome inactivation assays (data not shown), which were in the normal range, and 
consistent with random skewing seen in patients. Alternatively, PCDH19 may act non-cell 
autonomously to instruct the behaviour of neighbouring cells, for example, as is the case for 
other transmembrane protein based signalling pathways including Notch and Ephrin (69, 70). 
Cell tracing approaches (e.g. differential labelling of WT and KO) will be required to address 
this in future studies, preferably in vivo, or in NSPCs cultured at high density so as 
maintaining cell-cell contacts throughout differentiation. Interestingly, our initial mNSPC 
labelling experiment of dissociated single cell and low-density differentiation mosaic cultures 
revealed Pcdh19 can act cell-autonomously. However, this is not mutually exclusive with 
non-cell autonomous mechanism, and it is highly likely given the function of Pcdh19 in cell-
cell adhesion and communication that both can and will operate. Regardless of the 
mechanism, why Mosaic cultures behaved as KO cultures, and as such how this could be 
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pathogenic is puzzling, but perhaps relates to limitations of the in vitro approach we 
undertook which isolates cells from their native cellular architecture and environment.  
Indeed, in vivo NSPCs reside within specialised cellular environments, so-called stem cell 
niche’s, in which NSPCs are exposed to a milieu of instructive signalling events and 
behavioural cues (71). Our in vitro study design limits our ability to resolve the impact the 
native NSPC niche has on the behaviour of cells, the absence of which may have masked 
non-cell autonomous effects which potentially explain why the Mosaic cultures behaved as 
KO. As a case in point, during this study an additional Pcdh19 mouse model was established 
that enabled identification of KO and WT cells during mouse brain development, and showed 
segregation (or sorting) of KO and WT mNSPCs into contiguous blocks of only WT, or only 
KO cells just prior to, and during, neurogenesis (12). Our isolation of cells for in vitro 
analysis destroys this cellular niche architecture.  Furthermore we were unable to recapitulate 
this sorting phenomena when WT and KO mNSPCs were fluorescently labelled and cultured 
in vitro, and instead found KO and WT cells mixed extensively with one-another and showed 
no signs of segregation (data not shown). The differences between the spatial arrangement of 
KO and WT NSPCs in their native in vivo niche and in vitro might be important and 
potentially contribute to in vitro artefact. For example, if indeed MUT/KO hNSPCs acts non-
cell autonomously to instruct the behaviour of neighbouring WT hNSPCs as we speculate 
above, this would have large impact in vitro, (where KO and WT cells often neighbour each-
other), whilst in vivo, this effect would be negligible (as vast majority of WT and KO cells 
are spatially separated). Ultimately, it will be most valuable to validate our model of cellular 
heterochrony of neurogenesis in vivo using this newly developed mouse in future endeavours, 
in which one would expect the segregated contiguous blocks of WT or KO NSPCs to be 
undergoing neurogenesis at different rates or times. 
 
Conclusion 
Taken together this study points to a mechanism whereby temporal asynchrony (cellular 
heterochrony) of WT and MUT/KO NSPC differentiation when present in the same 
individual could contribute to the pathogenesis of PCDH19-GCE. Normal cortical brain 
development occurs if the population of NSPCs is undergoing homogeneous synchronous 
differentiation (whether it be wildtype or slightly premature), whilst pathogenesis can occur 
when mosaic populations of cells undergo differentiation at different rates. This is not likely 
to be the only mechanism underlying PCDH19-GCE development, as recent studies have also 
shown Pcdh19 provides a highly specific combinatorial adhesion-code during cortical 
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development leading to cellular sorting of Pcdh19 KO and Pcdh19 WT cells in the mouse 
cortex (12).  At a fundamental level, we have shown that WT and MUT/KO cells are 
essentially two different cell types as evidenced both at the transcript level and through 
differences in cellular behaviours (neuronal differentiation and migration). Thus this “cellular 
sorting” of WT and MUT/KO neuronal cells, through both cell autonomous effects 
(asynchrony of differentiation) and non-cell autonomous effects (altered cell-cell 
interactions) during cortical development is likely to result in the establishment of diverse 
neuronal networks. We can thus surmise PCDH19-GCE pathogenesis arises from the altered 
cortical development, converging on the role of X-inactivation leading to mosaicism and the 
fundamental differences in the WT and MUT/KO neuronal cells.    
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Figure Legends:  
Figure 1: Loss of Pcdh19 enhances neurogenesis of mNSPCs. A) Schematic of the 
experimental approach used to create cultures of Pcdh19 wildtype (WT), Knockout (KO) and 
mosaic cultures of mNSPCs. B) Principal component analysis (PCA) of gene expression 
profiles of undifferentiated and differentiated cultures of mNSPCs (n=3 cultures per type for 
both undifferentiated and differentiated states). Dashed circles show the clustering of WT 
away from the Mosaic and KO cultures in the differentiated mNSPC populations. C) 
Identification of genes displaying differential expression between the undifferentiated and 
differentiated mNSPC states, and their comparison between WT and KO cultures: 761 
differentially expressed genes were shared, and 302 DE genes were unique between the WT 
and KO cultures. D and E) The 302 DE genes unique to WT and KO mNSPC cultures were 
subjected to in-silico analysis to derive (D) enriched gene ontology terms for biological 
processes (DAVID
(72, 73)
) and (E) enriched pathways (KEGG
(74)
). F) Expression changes of 
unique DE genes with highly relevant roles in mNSPC differentiation and neuronal 
maturation. G and H). G. Representative immunofluorescent images used to quantitate 
percentage of neurons in culture using antibodies directed towards the neuronal specific βIII-
tubulin. H. Quantification of neural cell types. Graph values represent the mean values of n≥3 
biological replicates per culture type. Error bars=SEM. * p<0.05, Student’s T-test. 
Figure 2: Generation of hiPSCs expressing pathogenic PCDH19 alleles. A) Schematic of 
the pipeline used to reprogram fibroblasts into iPSCs. Fibroblasts are derived from both 
females with PCDH19-CGE, and a male with hemizygous pathogenic PCDH19 mutation. B) 
Summary of results from the reprogramming experiments. Note that karyotypically normal 
iPSCs expressing mutant PCDH19 alleles could only be derived from fibroblasts of the male 
donor (Individual 3). C-D) Characterisation of male iPSC clones. C) Representative 
immunofluorescence images hiPSC clone stained with antibodies against specific 
pluripotency marker proteins NANOG and OCT4. D) Representative metaphase spread 
showing normal karyotype; 46,XY. E) Representative hematoxylin and eosin stained sections 
of teratomas derived from male iPSC clones indicating the presence of tissue derivatives of 
the three embryonic germ layers (mesoderm: hyaline cartilage; endoderm: columnar 
epithelium; and ectoderm: pigmented neural epithelium). 
Figure 3: PCDH19 is highly expressed in iPSC derived hNSPCs. A) 
Immunofluorescences images showing the major developmental stages of the iPSC cortical 
differentiation protocol. Cultures were stained with antibodies against proteins specific for 
dorsal cortical hNSPC (PAX6, NESTIN), cell polarity markers (AF6 and N-CADHERIN) 
and neurons (NEUN, βIII-Tubulin, DCX and MAP2). B) RT-qPCR analysis of PCDH19 
mRNA expression across stages of cortical differentiation. Data from differentiation of both 
human embryonic stem cells (hESCs) and hiPSCs. Data combined from n=8 independent 
differentiation experiments. C) PCDH19 mRNA expression is upregulated in PCDH19 
mutant and mosaic cultures specifically at the neural rosette stage of cortical differentiation. 
iPSCs derived occurs only at the neural rosette stage of cortical differentiation. Error 
bars=SEM. * P< 0.05, ** P<0.01. by ordinary one-way ANOVA with Turkey’s multiple 
comparisons. Data combined from n=5 independent differentiation experiments per culture 
type (WT, MUT and Mosaic).  
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Figure 4: Profiling PCDH19 hiPSC neuronal differentiation with cell-specific marker 
gene expression. A-D) RT-qPCR analysis of mRNA expression of cell type specific markers 
during hiPSC neural differentiation. A) Neuroepithelial sheet stage. B) Neural rosette stage. 
C) Day 70 neurons stage. D) Day 90 neurons stage. n=3 independent experiments / culture 
type. * P< 0.05, ** P<0.01 by RM One-way ANOVA with the Greenhouse-Gessier 
correction and a Turkey’s multiple comparison test. Graph values are the mean ± SEM. 
Figure 5: Pathogenic PCDH19 mutation results in premature hNSPC neuronal 
differentiation. A-B) Increased neuronal cell numbers in MUT and Mosaic cultures of 
hNSPCs at neural rosette stage of differentiation. A)  Representative images of cultures 
stained with neuronal specific antibody βIII-Tubulin (Green), Phalloidin (Red), and DAPI 
(Blue). B) Quantification of the mean number of βIII-tubulin positive cells around the 
periphery of the neural rosette colonies relative to the area. n>10 replicates per genotype 
across 3 biological experiments. (C-D) Primary neurite length of neurons is increased in 
MUT and Mosaic cultures. C) Representative immunofluorescent images of neurons (β-III 
Tubulin (Green), DAPI (Blue)). D) Quantitation of the average primary neurite length. n>329 
neurons scored across 5 biological replicates per culture type. * P< 0.05, ** P<0.01 by RM 
One-way ANOVA with the Greenhouse-Gessier correction and a Turkey’s multiple 
comparison test. Graph values are the mean ± SEM. 
Figure 6: Pathogenic PCDH19 mutation yields reduced polarity in hNSPCs.  A) 
Schematic depicting the formation and disassembly of neural rosette structures as 
differentiation proceeds. B) Representative immunofluorescence highlighting co-localisation 
of enriched phalloidin staining with cell adhesion marker proteins N-CADHERIN (Green) 
and AFADIN (AF6: Cyan). Scale bar is 50μm. C) RT-qPCR analysis of mRNA expression of 
the NSPC cell adhesion / polarity marker gene N-CADHERIN. Error bars=SEM. n=5 
independent experiments/culture type. D) Average area of neural rosette colonies is 
consistent between WT, MUT and Mosaic cultures. Error bars=SEM. n>10 replicates per 
culture type across 3 biological experiments. * P< 0.05, ** P<0.01 by ordinary one-way 
ANOVA with Turkey’s multiple comparisons test. E) Representative immunofluorescent 
images of neural rosette colonies; Phalloidin (Red), DAPI (Blue). Box shows the enlarged 
image indicating the classification of neural rosette structure and foci. F). Quantification of 
the mean density of neural rosette structures in neural rosette colonies C) Quantification of 
the mean density of foci in neural rosette colonies D) Proportion of neural rosette structures 
to foci in the neural rosette colonies. Experiments F-G preformed in biological duplicate and 
analysed in technical triplicate (n>10 rosette colonies per culture type per triplicate). E) 
Quantification of the mean total area of the central lumen (polarised structures) relative to the 
area of the rosette colony. Experiment preformed in biological triplicate (n >13 rosette 
colonies per culture type per triplicate). Graph values represent the mean ± SEM. * P< 0.05, 
** P<0.01 by One-way ANOVA with Greenhouse-Gessier correction and a Turkey’s 
multiple comparison test. n≥60 neural rosette colonies for each culture type. 
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